Search Results
Department of Endocrinology and Diabetes, Monash Health, Victoria, Australia
Search for other papers by Chau Thien Tay in
Google Scholar
PubMed
Search for other papers by Rhonda Garrad in
Google Scholar
PubMed
Search for other papers by Aya Mousa in
Google Scholar
PubMed
Search for other papers by Mahnaz Bahri in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Monash Health, Victoria, Australia
Search for other papers by Anju Joham in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Monash Health, Victoria, Australia
Search for other papers by Helena Teede in
Google Scholar
PubMed
manifestations arise in childhood and health impacts evolve across adolescent years and adult life ( Teede et al. 2010 ). PCOS has significant metabolic (obesity, metabolic syndrome, impaired glucose tolerance, type 2 diabetes, cardiovascular risk factors
Search for other papers by Gabriel Forn-Cuní in
Google Scholar
PubMed
Search for other papers by Monica Varela in
Google Scholar
PubMed
Search for other papers by Conrado M Fernández-Rodríguez in
Google Scholar
PubMed
Search for other papers by Antonio Figueras in
Google Scholar
PubMed
Search for other papers by Beatriz Novoa in
Google Scholar
PubMed
diseases are part of a condition termed metabolic syndrome. The hepatic component of metabolic syndrome is non-alcoholic fatty liver disease (NAFLD). This term comprises a wide range of progressive liver injuries including bland steatosis, variable degrees
Search for other papers by Eun-Kyung Choi in
Google Scholar
PubMed
Search for other papers by Woon-Ki Kim in
Google Scholar
PubMed
Search for other papers by Ok-Joo Sul in
Google Scholar
PubMed
Search for other papers by Yun-Kyung Park in
Google Scholar
PubMed
Search for other papers by Eun-Sook Kim in
Google Scholar
PubMed
Search for other papers by Jae-Hee Suh in
Google Scholar
PubMed
Search for other papers by Rina Yu in
Google Scholar
PubMed
Search for other papers by Hye-Seon Choi in
Google Scholar
PubMed
role of TNFRSF14 in OVX-induced metabolic disturbances could aid in the design of a novel therapy for postmenopausal syndrome. Declaration of interest The authors declare that there is no conflict of interest that could be perceived as prejudicing the
Search for other papers by Malin Fex in
Google Scholar
PubMed
Search for other papers by Lisa M Nicholas in
Google Scholar
PubMed
Search for other papers by Neelanjan Vishnu in
Google Scholar
PubMed
Search for other papers by Anya Medina in
Google Scholar
PubMed
Search for other papers by Vladimir V Sharoyko in
Google Scholar
PubMed
Search for other papers by David G Nicholls in
Google Scholar
PubMed
Department of Chemistry, Center for Analysis and Synthesis, Lund University, Sweden
Search for other papers by Peter Spégel in
Google Scholar
PubMed
Search for other papers by Hindrik Mulder in
Google Scholar
PubMed
) of patients with T2D and metabolic traits have been published ( Saxena et al . 2007 , Scott et al . 2007 , Sladek et al . 2007 , Zeggini et al . 2007 , Gaulton et al . 2015 , Fuchsberger et al . 2016 ). The number of gene loci conferring
Search for other papers by J Hoppmann in
Google Scholar
PubMed
Search for other papers by N Perwitz in
Google Scholar
PubMed
Search for other papers by B Meier in
Google Scholar
PubMed
Search for other papers by M Fasshauer in
Google Scholar
PubMed
Search for other papers by D Hadaschik in
Google Scholar
PubMed
Search for other papers by H Lehnert in
Google Scholar
PubMed
Search for other papers by J Klein in
Google Scholar
PubMed
metabolic syndrome ( Hotamisligil et al . 1993 , 1995 ). The crosstalk between adipocytes and macrophages which infiltrate adipose tissue in obesity is considered to be crucial for the development of the pro-inflammatory state ( Bluher 2008 ). To date, the
Search for other papers by Sieneke Labruijere in
Google Scholar
PubMed
Search for other papers by E Leonie A F van Houten in
Google Scholar
PubMed
Search for other papers by René de Vries in
Google Scholar
PubMed
Search for other papers by Usha M Musterd-Bagghoe in
Google Scholar
PubMed
Search for other papers by Ingrid M Garrelds in
Google Scholar
PubMed
Search for other papers by Piet Kramer in
Google Scholar
PubMed
Search for other papers by A H Jan Danser in
Google Scholar
PubMed
Search for other papers by Carlos M Villalón in
Google Scholar
PubMed
Search for other papers by Jenny A Visser in
Google Scholar
PubMed
Search for other papers by Antoinette MaassenVanDenBrink in
Google Scholar
PubMed
are still unclear, but high levels of androgens are considered to play a crucial role in the etiology. PCOS patients suffer from dyslipidemia, obesity and metabolic syndrome ( Wild 2002 , Glueck et al . 2009 ), resulting in an increased risk for type
Search for other papers by Jinyu Ma in
Google Scholar
PubMed
Search for other papers by Yuejun Wang in
Google Scholar
PubMed
Search for other papers by Jie Ding in
Google Scholar
PubMed
Search for other papers by Shouping Zhang in
Google Scholar
PubMed
Search for other papers by Yinuo Yang in
Google Scholar
PubMed
Nantong Key Laboratory of Translational Medicine in Cardiothoracic Diseases, Institute of Translational Medicine in Cardiothoracic Diseases, Affiliated Hospital of Nantong University, Nantong, China
Search for other papers by Cheng Sun in
Google Scholar
PubMed
obesity at the early stages of the disease ( Ezenwaka et al. 2014 , Heianza et al. 2015 ). Abdominal obesity is an important cause of metabolic syndromes and impairs glucose tolerance ( Hossain et al. 2007 ). Therefore, slow or prevent body weight
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Cássio M Villicev in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Fatima R S Freitas in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Marcelo S Aoki in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Cássio Taffarel in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Thomas S Scanlan in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Anselmo S Moriscot in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Miriam O Ribeiro in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Antonio C Bianco in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Cecília H A Gouveia in
Google Scholar
PubMed
result in some therapeutically desirable effects, such as increased metabolic rate, lipolysis, cholesterol lowering, improvement of heart contractility and thyroid-stimulating hormone (TSH) suppression, which is beneficial in patients with thyroid cancer
Search for other papers by Milos Lazic in
Google Scholar
PubMed
Search for other papers by Fraser Aird in
Google Scholar
PubMed
Search for other papers by Jon E Levine in
Google Scholar
PubMed
Search for other papers by Andrea Dunaif in
Google Scholar
PubMed
have an increased prevalence of hyperandrogenemia, insulin resistance, and metabolic syndrome ( Sam et al . 2005 , 2006 ). Brothers of women with PCOS have elevated levels of dehydroepiandrosterone sulfate ( Legro et al . 2002 ) and metabolic
Search for other papers by Carla Tatone in
Google Scholar
PubMed
Search for other papers by Giovanna Di Emidio in
Google Scholar
PubMed
Search for other papers by Martina Placidi in
Google Scholar
PubMed
Search for other papers by Giulia Rossi in
Google Scholar
PubMed
Search for other papers by Stefania Ruggieri in
Google Scholar
PubMed
Search for other papers by Chiara Taccaliti in
Google Scholar
PubMed
Search for other papers by Angela D’Alfonso in
Google Scholar
PubMed
Search for other papers by Fernanda Amicarelli in
Google Scholar
PubMed
Search for other papers by Maurizio Guido in
Google Scholar
PubMed
hyperinsulinemia, type 2 diabetes mellitus, obesity, dyslipidemia, metabolic syndrome, and cardiovascular complications (reviewed by Carvalho et al. 2018 ). Insulin resistance is observed up to 47% in lean PCOS and up to 76% in obese PCOS ( Diamanti